Roche total laboratory automation system

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0220D0016
Awardee
Awarding agency
Task orders
5 $6,749,745 obligated

Award facts

Opportunity
Combined order value
$6,749,745 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 74% used
$9,160,241.71
Maximum order
$9,149,317.65
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
1 offer Only One Source
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The provided information details an Indefinite Delivery Contract (IDC) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated products and services.

The 5-year, $9,160,241.71 IDC allows DHA to issue delivery orders for Roche's Total Laboratory Automation Systems and Cobas 8000 analyzers to support operations at Madigan Army Medical Center in Tacoma, Washington. Under the IDC, DHA has awarded multiple firm fixed price delivery orders totaling over $4 million to date for the provision of laboratory automation equipment, reagents, services, training, and maintenance. These delivery orders aim to enhance the medical center's clinical testing capabilities in areas such as chemistry, immunochemistry, hematology, and molecular diagnostics. Roche Diagnostics holds several IDCs and Blanket Purchase Agreements with federal agencies, including the Department of Veterans Affairs and Department of Defense, to supply critical medical equipment and consumables across the healthcare system serving veterans, active duty personnel, and other federal patients.

Task orders

Transactions

Action Obligated Date
Exercise an Option P00009 · Exercise option 4, 1 october 2024 - 30 september 2025 $0
Supplemental Agreement for work within scope P00008 $0
Exercise an Option P00007 · Analyzers, reagents, supplies and consumables. The purpose of this modification is to exercise the third option period (01 OCT 2023 - 30 SEP 2024) $0
Other Administrative Action P00006 · Roche reagents, middleware software & cystatin c testing. MOD to restructure clins to be in compliance with dfars PGI 207.7103(a). Updated wawf clause: contract… $0
Exercise an Option P00005 · Chemistry analyzer reagents, supplies, training, and maintenance for an existing roche diagnostic total laboratory automation system. The purpose of the… $0
Supplemental Agreement for work within scope P00004 · Incorporate cystatin c testing into the contract. $0
Exercise an Option P00003 · RE-exercise clin 1002 to clear an error in the contract writing application. $0
Exercise an Option P00002 · Exercise first option period. $0
Supplemental Agreement for work within scope P00001 · 0001, REQ reagents, SVC, TNG, and maint $0
Original award $0

Quick answers

Who was awarded contract W81K0220D0016?

W81K0220D0016 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on October 1, 2020.

How much is contract W81K0220D0016 worth?

Orders under W81K0220D0016 have obligated $6,749,745. W81K0220D0016's own ceiling is $9,160,242. A single order can be worth up to $9,149,318.

How many orders have been placed under contract W81K0220D0016?

5 orders have been placed under W81K0220D0016, the latest on October 1, 2024.

Which agency awarded contract W81K0220D0016?

Medical Command (Department of the Army) awarded W81K0220D0016, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0220D0016?

W81K0220D0016 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0220D0016 competed?

The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV